Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Anteris Technologies Global Corp. - Common Stock
(NQ:
AVR
)
6.485
-0.215 (-3.21%)
Streaming Delayed Price
Updated: 3:31 PM EDT, May 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Anteris Technologies Global Corp. - Common Stock
< Previous
1
2
Next >
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
Today 8:39 EDT
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Announces Results for the First Quarter of 2026
May 12, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
May 05, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
April 28, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Reports 2025 Financial Results and Provides Corporate Update
February 26, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays
February 23, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises
January 22, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
January 22, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session.
↗
January 22, 2026
Via
Chartmill
Why Did AVR Stock Surge Pre-Market Today?
↗
January 21, 2026
The company unveiled a $200 million dilution alongside a $90 million investment from healthcare technology heavyweight Medtronic.
Via
Stocktwits
Nasdaq, S&P 500 Futures Rebound, All Eyes On Trump’s Davos Speech: Why TSLA, NVDA, NFLX, AVR Are On Traders' Radar Today
↗
January 21, 2026
Retail sentiment on Stocktwits on SPY and QQQ turned ‘extremely bearish’.
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
Economy
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
January 20, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Top movers in Tuesday's after hours session
↗
January 20, 2026
Via
Chartmill
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
January 20, 2026
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Wondering what's happening in today's after-hours session?
↗
December 31, 2025
Via
Chartmill
Top movers in Thursday's after hours session
↗
November 27, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
November 17, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Announces Results for the Third Quarter of 2025
November 12, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
November 03, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
October 28, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 28, 2025
Via
Benzinga
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
October 27, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
October 27, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 20, 2025
Via
Benzinga
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
October 15, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
September 19, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Top 2 Health Care Stocks That May Keep You Up At Night This Month
↗
September 18, 2025
Via
Benzinga
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
September 11, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
September 04, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
